Overview
- A UBS analyst re-rated NuScale to "sell" and set a $6 price target, triggering a sharp share decline after the note questioned the company's near‑term commercial readiness.
- Analysts project large negative free cash flow over the next few years, with UBS estimating roughly $700 million of burn for 2026–2028 and other polls pointing to about $1 billion.
- NuScale has NRC certification for its small modular reactor design but has not yet sold or built a reactor for a customer, leaving its valuation tied to expected future projects rather than current revenue.
- The company has signaled openness to raising capital through a share sale filing and reported sizable cash on hand today, but analysts say dilution or further funding rounds could be needed before commercial starts.
- Investor moves have been volatile, including an unexplained one‑day stock rally earlier this month that some traders linked to renewed interest in SMRs from AI and data‑center power demand, yet analysts stress that approvals, contracts and supply‑chain scale remain the decisive hurdles.